Exploitation of Mycobacterium tuberculosis Reporter Strains to Probe the Impact of Vaccination at Sites of Infection

PLoS Pathogens

Volumn 10, Issue 9, 2014, Pages

  Sukumar, Neelima ^a   Tan, Shumin ^a   Aldridge, Bree B ^b   Russell, David G ^a  

^a Department of Microbiology and Immunology ^*  (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE; ENHANCED GREEN FLUORESCENT PROTEIN; GAMMA INTERFERON; GENOMIC DNA; ISONIAZID; NITRIC OXIDE SYNTHASE; BCG VACCINE; NITRIC OXIDE; TUBERCULOSTATIC AGENT;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA REPLICATION; ENVIRONMENTAL STRESS; HISTOPATHOLOGY; HYPOXIA; IMMUNE RESPONSE; INFECTION CONTROL; MOLECULAR DYNAMICS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; TUBERCULOSIS; VACCINATION; ANIMAL; ANOXIA; C57BL MOUSE; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG; MACROPHAGE; METABOLISM; MICROBIOLOGY; PROCEDURES; REPORTER GENE;

MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; ANOXIA; ANTITUBERCULAR AGENTS; FLUORESCENT ANTIBODY TECHNIQUE; GENES, REPORTER; HOST-PATHOGEN INTERACTIONS; ISONIAZID; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION;

EID: 84907584291     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004394     Document Type: Article

References (38)

1. da Costa AC, Nogueira SV, Kipnis A, Junqueira-Kipnis AP, (2014) Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory. Front Immunol 5: 152.
2. Sable SB, Cheruvu M, Nandakumar S, Sharma S, Bandyopadhyay K, et al. (2011) Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination. PLoS ONE 6: e22718.
3. Bertholet S, Ireton GC, Ordway DJ, Windish HP, Pine SO, et al. (2010) A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis. Sci Transl Med 2: 53ra74.
4. Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, et al. (2011) A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 17: 189–194.
5. Orme IM, (2013) Vaccine development for tuberculosis: current progress. Drugs 73: 1015–1024.
6. Kaufmann SH, (2013) Tuberculosis vaccines: time to think about the next generation. Semin Immunol 25: 172–181.
7. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, et al. (2013) Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381: 1021–1028.
8. North RJ, Jung YJ, (2004) Immunity to tuberculosis. Annu Rev Immunol 22: 599–623.
9. Russell DG, (2007) Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5: 39–47.
10. Russell DG, Barry CE, 3rdFlynn JL, (2010) Tuberculosis: what we don't know can, and does, hurt us. Science 328: 852–856.
11. Gideon HP, Flynn JL, (2011) Latent tuberculosis: what the host “sees”? Immunol Res 50: 202–212.
12. Glaziou P, Falzon D, Floyd K, Raviglione M, (2013) Global epidemiology of tuberculosis. Semin Respir Crit Care Med 34: 3–16.
13. Flynn JL, Chan J, (2005) What's good for the host is good for the bug. Trends Microbiol 13: 98–102.
14. Russell DG, (2013) The evolutionary pressures that have molded Mycobacterium tuberculosis into an infectious adjuvant. Curr Opin Microbiol 16: 78–84.
15. Lin PL, Ford CB, Coleman MT, Myers AJ, Gawande R, et al. (2013) Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med 20: 75–79.
16. Via LE, Schimel D, Weiner DM, Dartois V, Dayao E, et al. (2012) Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [(1)(8)F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography. Antimicrob Agents Chemother 56: 4391–4402.
17. Tan S, Sukumar N, Abramovitch RB, Parish T, Russell DG, (2013) Mycobacterium tuberculosis responds to chloride and pH as synergistic cues to the immune status of its host cell. PLoS Pathog 9: e1003282.
18. Gill WP, Harik NS, Whiddon MR, Liao RP, Mittler JE, et al. (2009) A replication clock for Mycobacterium tuberculosis. Nat Med 15: 211–214.
19. Rohde KH, Veiga DF, Caldwell S, Balazsi G, Russell DG, (2012) Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection. PLoS Pathog 8: e1002769.
20. Flynn JL, Chan J, (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93–129.
21. Ohno H, Zhu G, Mohan VP, Chu D, Kohno S, et al. (2003) The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell Microbiol 5: 637–648.
22. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, et al. (2003) Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 198: 705–713.
23. Kumar A, Toledo JC, Patel RP, Lancaster JR, JrSteyn AJ, (2007) Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc Natl Acad Sci U S A 104: 11568–11573.
24. Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, et al. (2003) Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 48: 833–843.
25. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, et al. (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 94: 5243–5248.
26. Scanga CA, Mohan VP, Tanaka K, Alland D, Flynn JL, et al. (2001) The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect Immun 69: 7711–7717.
27. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178: 2243–2247.
28. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249–2254.
29. Cowley SC, Elkins KL, (2003) CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J Immunol 171: 4689–4699.
30. Reyes-Lamothe R, Possoz C, Danilova O, Sherratt DJ, (2008) Independent positioning and action of Escherichia coli replisomes in live cells. Cell 133: 90–102.
31. Berkmen MB, Grossman AD, (2006) Spatial and temporal organization of the Bacillus subtilis replication cycle. Mol Microbiol 62: 57–71.
32. Costes A, Lecointe F, McGovern S, Quevillon-Cheruel S, Polard P, (2010) The C-terminal domain of the bacterial SSB protein acts as a DNA maintenance hub at active chromosome replication forks. PLoS Genet 6: e1001238.
33. Gomez JE, McKinney JD, (2004) M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 84: 29–44.
34. Wayne LG, Sohaskey CD, (2001) Nonreplicating persistence of mycobacterium tuberculosis. Annu Rev Microbiol 55: 139–163.
35. Karakousis PC, Yoshimatsu T, Lamichhane G, Woolwine SC, Nuermberger EL, et al. (2004) Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. J Exp Med 200: 647–657.
36. Taneja NK, Dhingra S, Mittal A, Naresh M, Tyagi JS, (2010) Mycobacterium tuberculosis transcriptional adaptation, growth arrest and dormancy phenotype development is triggered by vitamin C. PLoS ONE 5: e10860.
37. Carroll P, Schreuder LJ, Muwanguzi-Karugaba J, Wiles S, Robertson BD, et al. (2010) Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters. PLoS ONE 5: e9823.
38. Aldridge BB, Fernandez-Suarez M, Heller D, Ambravaneswaran V, Irimia D, et al. (2012) Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 335: 100–104.